{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tenaya Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"TNYA"},"Address":{"label":"Address","value":"171 OYSTER POINT BOULEVARD,5TH FLOOR SUITE 500, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 825-6990"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine."},"CompanyUrl":{"label":"Company Url","value":"https://www.tenayatherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Faraz Ali","title":"Chief Executive Officer & Director"},{"name":"Kathy Ivey","title":"Senior Vice President-Research"},{"name":"Kee-Hong Kim","title":"Chief Technology Officer"},{"name":"Matthew Jay Pollman","title":"Senior Vice President-Clinical Development"},{"name":"Whittemore Tingley","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}